Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity
- PMID: 34209659
- PMCID: PMC8304378
- DOI: 10.3390/foods10071503
Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity
Abstract
Antiviral treatments inhibiting Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication may represent a strategy complementary to vaccination to fight the ongoing Coronavirus disease 19 (COVID-19) pandemic. Molecules or extracts inhibiting the SARS-CoV-2 chymotripsin-like protease (3CLPro) could contribute to reducing or suppressing SARS-CoV-2 replication. Using a targeted approach, we identified 17 plant products that are included in current and traditional cuisines as promising inhibitors of SARS-CoV-2 3CLPro activity. Methanolic extracts were evaluated in vitro for inhibition of SARS-CoV-2 3CLPro activity using a quenched fluorescence resonance energy transfer (FRET) assay. Extracts from turmeric (Curcuma longa) rhizomes, mustard (Brassica nigra) seeds, and wall rocket (Diplotaxis erucoides subsp. erucoides) at 500 µg mL-1 displayed significant inhibition of the 3CLPro activity, resulting in residual protease activities of 0.0%, 9.4%, and 14.9%, respectively. Using different extract concentrations, an IC50 value of 15.74 µg mL-1 was calculated for turmeric extract. Commercial curcumin inhibited the 3CLPro activity, but did not fully account for the inhibitory effect of turmeric rhizomes extracts, suggesting that other components of the turmeric extract must also play a main role in inhibiting the 3CLPro activity. Sinigrin, a major glucosinolate present in mustard seeds and wall rocket, did not have relevant 3CLPro inhibitory activity; however, its hydrolysis product allyl isothiocyanate had an IC50 value of 41.43 µg mL-1. The current study identifies plant extracts and molecules that can be of interest in the search for treatments against COVID-19, acting as a basis for future chemical, in vivo, and clinical trials.
Keywords: COVID-19; FRET assay; SARS-CoV-2 3CLPro; allyl isothiocyanate; curcumin; mustard seeds; natural compounds; plant extracts; turmeric; wall rocket.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization Coronavirus Disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. Coronavirus Disease (COVID-19) [(accessed on 8 April 2021)]; Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio....
-
- Islam M.R., Hoque M.N., Rahman M.S., Ul Alam A.S.M.R., Akther M., Puspo J.A., Akter S., Sultana M., Crandall K.A., Hossain M.A. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Sci. Rep. 2020;10:14004. doi: 10.1038/s41598-020-70812-6. - DOI - PMC - PubMed
-
- Laamarti M., Alouane T., Kartti S., Chemao-Elfihri M.W., Hakmi M., Essabbar A., Laamarti M., Hlali H., Bendani H., Boumajdi N., et al. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geodistribution and a rich genetic variations of hotspots mutations. PLoS ONE. 2020;15:e0240345. doi: 10.1371/journal.pone.0240345. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
